A carregar...

Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer

The anti-angiogenic agent bevacizumab has been approved for the treatment of non-small cell lung cancer, although the survival benefit associated with this agent is marginal, and toxicities and cost are substantial. A recent screen for selective inhibitors of endothelial cell proliferation identifie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aftab, Blake T., Dobromilskaya, Irina, Liu, Jun O., Rudin, Charles M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206167/
https://ncbi.nlm.nih.gov/pubmed/21896639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-0691
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!